Global Tourettes Syndrome Drugs Market 2023-2027

Description

List of Tables

The tourettes syndrome drugs market is forecasted to grow by USD 598.85 mn during 2022-2027, accelerating at a CAGR of 6.69% during the forecast period. The report on the tourettes syndrome drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing awareness about Tourette syndrome, increasing cases of Tourette syndrome across the world, and increasing demand for cost-effective treatments.

Technavio's tourettes syndrome drugs market is segmented as below:

By Product

Antipsychotics
Non-antipsychotics

By Distribution Channel

Offline
Online

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing R and D investments for Tourette syndrome as one of the prime reasons driving the tourettes syndrome drugs market growth during the next few years. Also, rising strategic alliances among vendors and increasing healthcare infrastructure expenditure will lead to sizable demand in the market.

The report on the tourettes syndrome drugs market covers the following areas:

Tourettes syndrome drugs market sizing
Tourettes syndrome drugs market forecast
Tourettes syndrome drugs market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading tourettes syndrome drugs market vendors that include Asarina Pharma AB, AstraZeneca, Bausch Health Co. Inc., Catalyst Pharmaceuticals Inc., Eli Lilly and Co., Emalex Biosciences Inc., H Lundbeck AS, Johnson and Johnson Services Inc., Medtronic Plc, OtsUKa Holdings Co. Ltd., Paragon Biosciences LLC, Questex LLC, Reviva Pharmaceuticals Holdings Inc, Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd. Also, the tourettes syndrome drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR75738

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global Tourettes syndrome drugs market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global tourettes syndrome drugs market 2017 - 2021 ($ million)
4.2 Product Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
4.3 Distribution Channel Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Product

6.1 Market segments
Exhibit 30: Chart on Product - Market share 2022-2027 (%)
Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 Antipsychotics - Market size and forecast 2022-2027
Exhibit 34: Chart on Antipsychotics - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Antipsychotics - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Antipsychotics - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Antipsychotics - Year-over-year growth 2022-2027 (%)
6.4 Non-antipsychotics - Market size and forecast 2022-2027
Exhibit 38: Chart on Non-antipsychotics - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Non-antipsychotics - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Non-antipsychotics - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Non-antipsychotics - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Product
Exhibit 42: Market opportunity by Product ($ million)
Exhibit 43: Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by Distribution Channel

7.1 Market segments
Exhibit 44: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibit 45: Data Table on Distribution Channel - Market share 2022-2027 (%)
7.2 Comparison by Distribution Channel
Exhibit 46: Chart on Comparison by Distribution Channel
Exhibit 47: Data Table on Comparison by Distribution Channel
7.3 Offline - Market size and forecast 2022-2027
Exhibit 48: Chart on Offline - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
Exhibit 50: Chart on Offline - Year-over-year growth 2022-2027 (%)
Exhibit 51: Data Table on Offline - Year-over-year growth 2022-2027 (%)
7.4 Online - Market size and forecast 2022-2027
Exhibit 52: Chart on Online - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Online - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Online - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Online - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Distribution Channel
Exhibit 56: Market opportunity by Distribution Channel ($ million)
Exhibit 57: Data Table on Market opportunity by Distribution Channel ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 59: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 61: Chart on Geographic comparison
Exhibit 62: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 83: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 UK - Market size and forecast 2022-2027
Exhibit 87: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.10 China - Market size and forecast 2022-2027
Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)
9.11 Canada - Market size and forecast 2022-2027
Exhibit 95: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 99: Market opportunity By Geographical Landscape ($ million)
Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 101: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 103: Overview on factors of disruption
11.4 Industry risks
Exhibit 104: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 105: Vendors covered
12.2 Market positioning of vendors
Exhibit 106: Matrix on vendor position and classification
12.3 Asarina Pharma AB
Exhibit 107: Asarina Pharma AB - Overview
Exhibit 108: Asarina Pharma AB - Product / Service
Exhibit 109: Asarina Pharma AB - Key offerings
12.4 AstraZeneca
Exhibit 110: AstraZeneca - Overview
Exhibit 111: AstraZeneca - Product / Service
Exhibit 112: AstraZeneca - Key news
Exhibit 113: AstraZeneca - Key offerings
12.5 Bausch Health Co. Inc.
Exhibit 114: Bausch Health Co. Inc. - Overview
Exhibit 115: Bausch Health Co. Inc. - Business segments
Exhibit 116: Bausch Health Co. Inc. - Key news
Exhibit 117: Bausch Health Co. Inc. - Key offerings
Exhibit 118: Bausch Health Co. Inc. - Segment focus
12.6 Catalyst Pharmaceuticals Inc.
Exhibit 119: Catalyst Pharmaceuticals Inc. - Overview
Exhibit 120: Catalyst Pharmaceuticals Inc. - Product / Service
Exhibit 121: Catalyst Pharmaceuticals Inc. - Key offerings
12.7 Eli Lilly and Co.
Exhibit 122: Eli Lilly and Co. - Overview
Exhibit 123: Eli Lilly and Co. - Product / Service
Exhibit 124: Eli Lilly and Co. - Key news
Exhibit 125: Eli Lilly and Co. - Key offerings
12.8 Emalex Biosciences Inc.
Exhibit 126: Emalex Biosciences Inc. - Overview
Exhibit 127: Emalex Biosciences Inc. - Product / Service
Exhibit 128: Emalex Biosciences Inc. - Key offerings
12.9 H Lundbeck AS
Exhibit 129: H Lundbeck AS - Overview
Exhibit 130: H Lundbeck AS - Product / Service
Exhibit 131: H Lundbeck AS - Key offerings
12.10 Johnson and Johnson Services Inc.
Exhibit 132: Johnson and Johnson Services Inc. - Overview
Exhibit 133: Johnson and Johnson Services Inc. - Business segments
Exhibit 134: Johnson and Johnson Services Inc. - Key news
Exhibit 135: Johnson and Johnson Services Inc. - Key offerings
Exhibit 136: Johnson and Johnson Services Inc. - Segment focus
12.11 Medtronic Plc
Exhibit 137: Medtronic Plc - Overview
Exhibit 138: Medtronic Plc - Business segments
Exhibit 139: Medtronic Plc - Key news
Exhibit 140: Medtronic Plc - Key offerings
Exhibit 141: Medtronic Plc - Segment focus
12.12 Otsuka Holdings Co. Ltd.
Exhibit 142: Otsuka Holdings Co. Ltd. - Overview
Exhibit 143: Otsuka Holdings Co. Ltd. - Business segments
Exhibit 144: Otsuka Holdings Co. Ltd. - Key offerings
Exhibit 145: Otsuka Holdings Co. Ltd. - Segment focus
12.13 Paragon Biosciences LLC
Exhibit 146: Paragon Biosciences LLC - Overview
Exhibit 147: Paragon Biosciences LLC - Product / Service
Exhibit 148: Paragon Biosciences LLC - Key offerings
12.14 Questex LLC
Exhibit 149: Questex LLC - Overview
Exhibit 150: Questex LLC - Product / Service
Exhibit 151: Questex LLC - Key offerings
12.15 Reviva Pharmaceuticals Holdings Inc
Exhibit 152: Reviva Pharmaceuticals Holdings Inc - Overview
Exhibit 153: Reviva Pharmaceuticals Holdings Inc - Product / Service
Exhibit 154: Reviva Pharmaceuticals Holdings Inc - Key offerings
12.16 Sun Pharmaceutical Industries Ltd.
Exhibit 155: Sun Pharmaceutical Industries Ltd. - Overview
Exhibit 156: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibit 157: Sun Pharmaceutical Industries Ltd. - Key offerings
12.17 Teva Pharmaceutical Industries Ltd.
Exhibit 158: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 159: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 160: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 161: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 162: Teva Pharmaceutical Industries Ltd. - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 163: Inclusions checklist
Exhibit 164: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 165: Currency conversion rates for US$
13.4 Research methodology
Exhibit 166: Research methodology
Exhibit 167: Validation techniques employed for market sizing
Exhibit 168: Information sources
13.5 List of abbreviations
Exhibit 169: List of abbreviations